Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 19, Issue 8, Pages 695-705
Publisher
Informa UK Limited
Online
2018-04-06
DOI
10.1080/15384047.2018.1450116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response
- (2017) Melanie J. McCoy et al. Oncotarget
- Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer
- (2017) Guoliang Yang et al. Oncotarget
- The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy
- (2017) Hirokazu Shoji et al. Oncotarget
- Cellular immunity augmentation in mainstream oncologic therapy
- (2017) Daohong Chen et al. Cancer Biology & Medicine
- Myeloid-derived suppressor cells and their role in pancreatic cancer
- (2016) M Pergamo et al. CANCER GENE THERAPY
- Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma
- (2016) Eishiro Mizukoshi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen
- (2016) Emeric Limagne et al. CANCER RESEARCH
- Immunotherapy with methyl gallate, an inhibitor of Treg cell migration, enhances the anti-cancer effect of cisplatin therapy
- (2016) Hyunseong Kim et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients
- (2016) Athanasios Kotsakis et al. Scientific Reports
- The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy
- (2016) Mario Roselli et al. OncoImmunology
- The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
- (2016) Alexander S. Baras et al. OncoImmunology
- Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
- (2016) Rikke B. Holmgaard et al. EBioMedicine
- St Gallen International Expert Consensus on the primary therapy of early breast cancer: an invaluable tool for physicians and scientists
- (2015) M. Ignatiadis et al. ANNALS OF ONCOLOGY
- Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
- (2015) M J McCoy et al. BRITISH JOURNAL OF CANCER
- Using chemo-drugs or irradiation to break immune tolerance and facilitate immunotherapy in solid cancer
- (2015) Yawen Zheng et al. CELLULAR IMMUNOLOGY
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
- (2015) Douglas Marvel et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of a FOXP3+CD3+CD56+ population with immunosuppressive function in cancer tissues of human hepatocellular carcinoma
- (2015) Xiaofeng Li et al. Scientific Reports
- The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer
- (2015) Mahiru Kawano et al. Scientific Reports
- Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy
- (2014) Alessandra Romano et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chemotherapeutic Targeting of Cancer-Induced Immunosuppressive Cells
- (2014) D. Alizadeh et al. CANCER RESEARCH
- Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion
- (2014) Alessia Zoso et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Noncanonical NF-κB Activation Mediates STAT3-Stimulated IDO Upregulation in Myeloid-Derived Suppressor Cells in Breast Cancer
- (2014) Jinpu Yu et al. JOURNAL OF IMMUNOLOGY
- Accuracy and Reproducibility of HER2 Status in Breast Cancer Using Immunohistochemistry: A Quality Control Study in Tuscany Evaluating the Impact of Updated 2013 ASCO/CAP Recommendations
- (2014) S. Bianchi et al. PATHOLOGY & ONCOLOGY RESEARCH
- Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
- (2013) J. Yu et al. JOURNAL OF IMMUNOLOGY
- Upregulated Expression of Indoleamine 2, 3-Dioxygenase in Primary Breast Cancer Correlates with Increase of Infiltrated Regulatory T CellsIn Situand Lymph Node Metastasis
- (2011) Jinpu Yu et al. Clinical & Developmental Immunology
- Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
- (2009) P.-Y. Pan et al. CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now